Insights / Media Coverage How Venture Capital Funds Could Shrink During the Coronavirus Crisis May 15, 2020
Insights / Experience Fenwick Represents DexCom in $1.05B Convertible Senior Notes Offering May 14, 2020
Insights / Experience Fenwick Represents Aeglea BioTherapeutics in $138M Public Offering May 12, 2020
Insights / Experience Fenwick Represents Santen Pharmaceutical in Licensing and Commercialization Agreement with jCyte May 12, 2020
Insights / Publication Now Final §901(m) Regulations Relax Few of the Rules from the Proposed Regulations May 8, 2020
